Cite
Galectin-3 is associated with left ventricular reverse remodeling and outcome after percutaneous mitral valve repair
MLA
Martin Duckheim, et al. “Galectin-3 Is Associated with Left Ventricular Reverse Remodeling and Outcome after Percutaneous Mitral Valve Repair.” International Journal of Cardiology, vol. 263, Nov. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....60e6537b93294ca2b857c56f9e92f50d&authtype=sso&custid=ns315887.
APA
Martin Duckheim, Johannes Patzelt, Iris I. Mueller, Christine S. Zuern, Niklas Floss, Meinrad Gawaz, Andreas E. May, Karin Mueller, & Christian Eick. (2017). Galectin-3 is associated with left ventricular reverse remodeling and outcome after percutaneous mitral valve repair. International Journal of Cardiology, 263.
Chicago
Martin Duckheim, Johannes Patzelt, Iris I. Mueller, Christine S. Zuern, Niklas Floss, Meinrad Gawaz, Andreas E. May, Karin Mueller, and Christian Eick. 2017. “Galectin-3 Is Associated with Left Ventricular Reverse Remodeling and Outcome after Percutaneous Mitral Valve Repair.” International Journal of Cardiology 263 (November). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....60e6537b93294ca2b857c56f9e92f50d&authtype=sso&custid=ns315887.